Oral sildenafil as a rescue therapy in presumed acute pulmonary hypertensive crisis

Pediatrics. 2013 Feb;131(2):e626-8. doi: 10.1542/peds.2012-0587. Epub 2013 Jan 6.

Abstract

A 23-week-old baby, born at 26(+2) weeks, presented to the hospital with critical respiratory failure, which was impossible to stabilize. She had unstable oxygen saturations between 35% and 95%. A presumptive diagnosis of bronchopulmonary dysplasia with associated pulmonary hypertensive crisis was made. In the absence of inhaled nitric oxide, 2 oral doses of 1 mg/kg sildenafil were given, with a dramatic improvement 30 to 45 minutes later. Her oxygenation index fell from 43 to 14. She made a full recovery and was discharged from the hospital 2 weeks later.

Publication types

  • Case Reports

MeSH terms

  • Administration, Oral
  • Bronchopulmonary Dysplasia / blood
  • Bronchopulmonary Dysplasia / complications
  • Bronchopulmonary Dysplasia / diagnosis
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Heart Arrest / blood
  • Heart Arrest / etiology
  • Humans
  • Hypertension, Pulmonary / blood
  • Hypertension, Pulmonary / diagnosis
  • Hypertension, Pulmonary / drug therapy*
  • Infant
  • Infant, Newborn
  • Infant, Premature, Diseases / blood
  • Infant, Premature, Diseases / diagnosis
  • Infant, Premature, Diseases / drug therapy*
  • Intensive Care Units, Neonatal
  • Intubation, Gastrointestinal
  • Oxygen / blood
  • Phosphodiesterase 5 Inhibitors / administration & dosage*
  • Phosphodiesterase 5 Inhibitors / adverse effects
  • Piperazines / administration & dosage*
  • Piperazines / adverse effects
  • Purines / administration & dosage
  • Purines / adverse effects
  • Respiratory Insufficiency / blood
  • Respiratory Insufficiency / diagnosis
  • Respiratory Insufficiency / drug therapy*
  • Sildenafil Citrate
  • Sulfones / administration & dosage*
  • Sulfones / adverse effects
  • Vasodilator Agents / administration & dosage*
  • Vasodilator Agents / adverse effects

Substances

  • Phosphodiesterase 5 Inhibitors
  • Piperazines
  • Purines
  • Sulfones
  • Vasodilator Agents
  • Sildenafil Citrate
  • Oxygen